HIT:

Histamine intolerance

DAO:

Diamine oxidase

HIT:

Histaminintoleranz

DAO:

Diaminooxidase

Introduction

Histamine intolerance (HIT) is mainly caused by ingestion of food containing high amounts of histamine by people with low intestinal histamine inactivation and degradation or inhibition of this activity by other food constituents or drugs. This leads to resorption of histamine, a biogenic amine, in amounts sufficient to cause adverse reactions [15]. The main enzyme for inactivating and metabolizing ingested histamine is diamine oxidase (DAO). DAO is a secretory enzyme that acts extracellularly to oxidatively deaminate the primary amino group of histamine yielding imidazole acetaldehyde [2, 5]. Impaired histamine degradation based on reduced DAO activity and the resulting excess in histamine may cause a variety of symptoms, including gastrointestinal discomfort associated with vomiting or diarrhea, abdominal pain, headache, urticaria, rhinitis, pruritus, flushing, asthma-like symptoms, cardiovascular complaints such as hypotension and tachycardia, and other conditions, often mimicking an allergic reaction [16].

HIT symptoms are mainly provoked by foods with high amounts of histamine, such as alcoholic beverages (especially red wine and champagne), cheese (especially aged), meat (especially cured), and fish. In addition, many foods, such as citrus fruits and nuts, have the ability to release histamine from tissue mast cells. Besides, because of high histamine intake, DAO-blocking drugs or drugs that release histamine such as contrast media, muscle relaxants, narcotics, analgesics, local anesthetics, diuretics, antibiotics, and so on can be causative agents for HIT [14].

Due to the multifaceted symptoms and multiple organs involved, the existence of HIT is frequently underestimated, or its symptoms are misinterpreted [3, 4]. Approximately 1–3 % of the population has HIT, and the majority (80 %) of these people are middle-aged [3].

HIT is commonly diagnosed based solely on subjective reporting of symptoms instead of following systematic diagnostic procedures based on objective laboratory and physical parameters [4, 5]. A diagnosis of HIT is made based on the presentation of at least two typical symptoms of HIT and improvement from using a histamine-free diet and antihistamines [15]. Although the gold standard in diagnosis is a double-blind, placebo-controlled histamine provocation after eating a histamine-free diet for 4 weeks, in a patient clinically suspected of having HIT, determination of DAO activity in serum might be useful for diagnosing HIT. There is some controversy regarding the usefulness of determining DAO activity [1, 3, 711].

Our study sets out to measure the serum DAO activity in patients with clinically suspected HIT and compare the results with healthy controls that have no histamine-related problems. Furthermore, in patients with highly reduced serum DAO activity, a prospective study was conducted. In this study, we addressed the effects of a histamine-free diet on clinical symptoms and serum DAO activity in histamine-intolerant patients, both before and after the diet.

Materials and methods

Study subjects

The study group consisted of 316 adult patients (median age 45 years; range 14–83 years; 207 female and 109 male) with suspected HIT and 55 healthy controls (median age 41 years; range 17–74 years; 37 female and 18 male) without any HIT symptoms (Table 1). This group was recruited at the Golnik University Clinic of Respiratory and Allergic Diseases over a period of 3.5 years, from January 2006 to May 2009. All patients recruited had been subject to the usual tests for food allergy (skin prick tests, specific IgE, and/or oral provocation tests) in order to exclude food allergy. Furthermore, all patients were regularly observed and information regarding clinical signs and symptoms of histamine effects were also recorded.

Table 1 Demographic data of patients and healthy controls

Of these patients, 20 with highly reduced initial serum DAO activity (< 40 HDU/ml) were selected. Those patients went on a histamine-free diet. After 6–12 months of this diet, all clinical parameters and serum for determination of DAO activity were taken again.

Determination of histamine-degradation activity by diamine oxidase (DAO)

Serum DAO activity was measured with enzyme immunoassay for the quantitative determination of histamine-degradation activity by DiAmineOxidase (DAO) in serum and EDTA-plasma (D-HIT, Sciotec, Austria) in accordance with the manufacturer’s instructions. We used the manufacturer’s recommended reference values: normal activity of DAO > 80 HDU/ml, reduced activity of DAO 40–80 HDU/ml, and highly reduced activity of DAO < 40 HDU/ml, for evaluation. One HDU (histamine degrading unit) corresponds to the DAO activity that degrades 1 pmol/ml (0.11 ng/ml) of histamine.

Statistical analyses

Data distribution was recalculated using the Shapiro-Wilk test. As the data were not normally distributed, we performed a Mann-Whitney test and/or Wilcoxon test. Probability values of P < 0.05 were accepted as significant. Analyses were performed with GraphPad Prism 5.

Results

We found that DAO activity was significantly lower in patients than in healthy control subjects (P < 0.0001, Mann-Whitney test) as seen in Fig. 1. Moreover, 199 of 316 (63 %) patients had reduced DAO activity according to the manufacturer’s reference values (< 80 HDU/ml) in comparison to only 12 of 55 (22 %) control subjects. Furthermore, 54 (17 %) patients, but no healthy control subject, had highly reduced DAO activity ( < 40 HDU/ml) (Fig. 2). The main symptoms in patients with highly reduced serum DAO activity involved the skin in 83 % (urticaria, angioedema, pruritus, and erythema), the gastrointestinal tract in 52 % (tenesmus, diarrhea, oral itching, abdominal pain, vomiting, constipation, and burping), the respiratory system in 26 % (cough, bronchospasm, rhinitis, hoarseness, and sinusitis), and the eyes in 9 %. Other symptoms (in 6 % of cases) were headache, conjunctivitis, hot flashes, aphthae, swollen joints, and paresthesia in the hands. The main causes of symptoms were fruits such as citrus fruits and strawberries, animal foods such as meat and fish, alcoholic beverages such as wine and beer, cheese, chocolate, and additives and spices.

Fig. 1
figure 1

DAO activity in patients and healthy controls. The results are depicted as medians with interquartile ranges

Fig. 2
figure 2

DAO activity according to the D-HIT reference values in patients and in healthy controls

We selected 20 patients with highly reduced initial serum DAO activity (< 40 HDU/ml). These patients went on a histamine-free diet (avoidance of histamine-containing food, histamine-releasing substances, and substances that inhibit DAO) and after 6–12 months of the diet all clinical parameters and the serum for determination of DAO activity were taken again. In all the 20 patients the main clinical symptoms typical of HIT had disappeared or at least were highly diminished. Furthermore, in all patients the measured values for serum DAO activity increased significantly following the histamine-free diet (P < 0.0001) above the levels for highly reduced activity based on the reference values (< 40 HDU/ml) (Fig. 3). In patients who reported diet errors, symptoms reappeared after the intake of food and beverages with high histamine content, such as wine, beer, aged cheese, salami, and chocolate.

Fig. 3
figure 3

Serum values of DAO activity in 20 patients before and after the histamine-free diet

Discussion

The major problems in diagnosing HIT is the lack of in vitro diagnostic tests and highly variable and heterogeneous symptoms after the intake of histamine-rich food, alcoholic beverages, or histamine-releasing or DAO-blocking drugs [2, 3, 5, 6]. Definitive diagnosis necessitates double-blind, placebo-controlled oral histamine provocation with determination of plasma histamine concentrations and objective physical parameters [3, 5, 6]. However, the interpretation of provocation results is often difficult because of lack of symptom reproducibility [6, 12]. Furthermore, even otherwise healthy subjects may respond to a standard histamine provocation using 75 mg liquid histamine [13]. Therefore, the need for an objective diagnostic test is more than evident. In cases of confirmed HIT, a histamine-free diet represents an effective treatment and should be advised [3, 5]. The role of DAO activity in serum as well as its use as a diagnostic tool has been addressed several times, frequently with contradictory results and conclusions [3, 711]. Some authors still deny the role of DAO in HIT despite clinical symptoms, excluded allergy, and lower DAO activity [10, 11].

In our study, we analyzed the results from 316 cases with clinical signs of HIT recruited at our hospital over a period of 3.5 years. Our results show that the determination of serum DAO activity is a useful tool in HIT diagnosis, especially in patients with highly reduced DAO activity. Detailed case histories, negative allergy tests (exclusion of food allergy), and reduced serum DAO activity made it possible to diagnose HIT. Moreover, DAO activity in patients was much lower than in healthy controls, and the patients with highly reduced DAO activity had several typical symptoms of HIT after the intake of histamine-rich food. The main clinical symptoms involved the skin, gastrointestinal system, respiratory system, and eyes.

Therapy for HIT is mainly based on a histamine-free diet [24, 9, 14]. The patients with highly reduced DAO activity were put on a histamine-free diet and after the diet the majority of symptoms disappeared and the included patients’ quality of life significantly improved, confirming the usefulness of diet therapy in addition to supporting the diagnosis of HIT along with the involvement of DAO in it. Furthermore, DAO activity increased in all patients on the diet. These findings are consistent with those of another study in which an increase of DAO activity along with a reduction in symptoms was observed in migraine patients following a histamine-free diet [9]. The role of a histamine-free diet in DAO activity conforms with the idea that jejunal DAO is relieved with lower histamine intake, which indirectly activates the enzyme and results in more histamine being effectively eliminated [9, 15].

Based on our observations, we can conclude that determination of serum DAO activity is a useful diagnostic tool, along with a detailed history, for diagnosing HIT. It should be performed in patients suspected of having HIT with symptoms such as headache, tachycardia, urticaria, pruritus, diarrhea, and hypotension. Furthermore, our results showed the benefit of a histamine-free diet because after following the diet the majority of histamine-related symptoms disappeared and the serum DAO activity increased.